| Catalog No. | HB996046 |
|---|
| Species reactivity | Human |
|---|
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| Host species | Mouse |
|---|
| Isotype | (scFv-kappa-heavy)-(scFv-heavy-kappa) |
|---|
| Expression system |
Mammalian Cells |
| Clonality |
Monoclonal |
| Target |
CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain |
| Endotoxin level |
Please contact the lab for this information. |
| Purity |
>95% purity as determined by SDS-PAGE. |
| Purification |
Purified by Nickel column. |
| Accession |
P15391 & P07766 |
| Form |
Liquid |
| Storage buffer |
30 mM Histidine, pH5.8, 10% sucrose, 0.02% Tween80 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
|
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | Bispecific, CD19, AMG103, BITEMT-103, MEDI-538, MT103, bscCD19xCD3, 853426-35-4 |
|---|
| Background | Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia.
|
|---|
| Note |
For research use only. Not suitable for clinical or therapeutic use. |
中文
English
